Objective:To explore the clinical efficacy of cognitive insight therapy for alexithymia in patients with persistent somatoform pain disorder.Methods:Totally 60 patients with persistent somatoform pain disorder were divided into observation group (n=30) and control group (n=30).All the patients were treated with antidepressants (Duloxetine),and those in the observation group received cognitive insight therapy additionally.The efficacy was evaluated with the Toronto alexithymia scale (TAS) before and after treatment.Results:After treatment for 8 weeks,the total score of TAS,scores of factor Ⅰ,factor Ⅱ and factor Ⅳ in observation group were significantly lower than those before treatment and control group(P<0.05),and there was no significant difference in the score of factor Ⅲ in observation group and all scores in control group.Conclusion:Cognitive insight therapy can effectively treat alexithymia in patients with persistent somatoform pain disorder. |